Skip to main content

UCare joins push to cap insulin costs at $25/month

Minnesota insurer UCare said Wednesday it would limit out-of-pocket insulin payments to $25 a month, the latest industry response to a growing outcry over rising costs for treating diabetes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.